Improving Specificity in your Immunoassay

Many assay developers face problems with accuracy in their immunoassays. Non-specific binding and poor reagent quality can make it hard to trust results, leading to confusion over true positives and negatives.

This problem often points back to one key concept: specificity.

Specificity is critical in any protein-based immunoassay, including ELISA applications. Specificity makes sure the signal you detect matches only the target analyte, not unrelated substances.

This blog will explain the importance of specificity in diagnostics and how to improve it using optimal reagents and practices.

Understanding Specificity in Immunoassays

Specificity in immunoassays refers to the ability of a test to identify only the target analyte, without interference from other substances. High specificity reduces the risk for false positives, ensuring accurate results.

Defining Specificity

Specificity measures how well an immunoassay identifies a target analyte without reacting to other substances. This property relies on the selectivity of antigen or antibody reagents and is essential in achieving improved performance in both research and clinical diagnostics.

Immunoassays, such as ELISA applications, depend on interactions between antigens and antibodies to detect and quantify analytes within biological samples.  High specificity ensures that the detected signal truly represents the presence of a specific antigen or antibodyThe Importance of Specificity in Immunoassays

High specificity is required in immunoassays to ensure that only the target analyte triggers a measurable response. Cross-reactivity or non-specific binding can interfere with results and ultimately increases the risk for false positives and reduces the number of true negatives.

For example, excess concentrations of detection antibody in an ELISA may lead to significant non-specific binding; thus, optimizing detection antibody concentration may improve accuracy and reliability.

How Do Immunoassay Tests Work?

Immunoassay testing works by using antibodies to detect small biological substances in the blood and other bodily fluids. The method follows the aspect that particular antigens bind to specific newly introduced antibodies, thereby stimulating an immune response. This refers to specificity, as antibodies are highly specific to analytes such as hormones, nucleoproteins, and peptides, among others. Detection of analytes becomes successful through the formation of antigen-antibody complexes.  For example, in colorimetric immunoassays, a color change occurs, which indicates the presence of the analyte in question. The observed color symbolizes the amount of targeted molecules present in the test solution.

Factors Affecting Specificity

Non-specific binding often detracts from the accuracy of immunoassays. The stability of reagents also plays a crucial role in influencing overall assay performance.

Surmodics IVD provides immunoassay developers with the critical components they need to build reliable, robust, and accurate immunoassay tests. Surmodics broad portfolio includes the industry’s gold standard in protein stabilizers/blocking buffers designed to increase sensitivity and specificity while decreasing non-specific binding.

Additionally, Surmodics IVD offers best-in-class detection substrates for color (TMB, ABTS, PNPS, BCIB/NBT) and light (Chemiluminescent) development as well as a selection of immunoassay reagents including our high-performance diluents designed to reduce matrix interferences including Human Anti-Mouse Antibodies (HAMA) and Rheumatoid Factor (RF) interferences.

Non-Specific Binding

Non-Specific binding (NSB) refers to an occurrence of an antibody binding to unintended proteins, receptors, or transporters. This binding of assay antibodies is not correlated with the specificity of the antibodies.

The stability of reagents plays a crucial role as well. If reagents degrade or become contaminated, specific reactions may fail while non-specific interactions rise.

Surmodics’ protein stabilizers, blockers & diluents help to reduce non-specific binding while maintaining and even increasing signal-to-noise ratios. Request free samples for evaluation today and connect with one of our immunoassay experts to learn more!

Stability of Reagents

Immunoassay reagents play a critical role in the specificity of diagnostic applications. Proper reagent stability helps maintain performance over time. Instability can lead to degradation of the protein and loss of activity, impacting assay results.

Proteins play the most critical role in immunoassays. They act as the detection antigen or antibody that assay developers use to determine whether a disease state is present. Preserving these proteins is essential in determining accurate results. When evaluating stability, assay developers must also consider the shelf life and storage conditions of their reagents. Surmodics IVD offers the industry’s gold standard in shelf life and stability.

Surmodics IVD’s dried protein stabilizers and blockers are designed to preserve the conformation and activity of dried proteins coated on a wide range of surfaces, keeping antibodies and antigens at peak performance for long durations. At the same time, the blocking mechanisms in these reagents reduce non-specific binding of interfering proteins to maximize assay sensitivity.

By ensuring that reagents remain stable, developers enhance both sensitivity and specificity during testing processes.

Quality of Antibodies and Antigens

High-quality antibodies and antigens also contribute to the success of immunoassays. Specificity in these assays depends on the effectiveness of antigen and antibody reagents.

As the exclusive North American representative of BBI Solutions antigens and antibodies, Surmodics IVD offers a comprehensive panel of autoimmune disease, infectious disease, allergy antigens and antibodies that provide outstanding assay performance for in vitro diagnostics applications.

BBI Solutions’ recombinant and native antigens have a proven track record for quality and sensitivity in ELISA, Western Blot and lateral flow applications. The lot-to-lot consistency of these antigens reduces development time and increases productivity of immunoassay developers.

Strategies to Improve Specificity

To improve specificity in an immunoassay, it is important for assay developers to consider the immunoassay reagents they are utilizing. Surmodics IVD’s stabilizers/blockers help to improve specificity, stability, and sensitivity of immunoassays.

Surmodics’ IVD’s dried protein stabilizers and blockers, StabilCoat™, StabilGuard™ and StabilBlock™, StabilMaX™ offer assay developers unmatched stabilization of dried proteins and blocking efficacy in a one-step process. These immunoassay reagents are designed to preserve the conformation and activity of dried proteins coated on a wide range of surfaces, keeping antibodies and antigens at peak performance for long durations. At the same time, the blocking mechanisms in these reagents reduce non-specific binding of interfering proteins to maximize assay sensitivity. Surmodics’ dried protein stabilizers and blockers are the industry gold standard for stability and blocking efficacy. The result is immediate improvement of assay performance in a one-step process for streamlined manufacturing.

Assay developers need numerous blocking mechanisms while selecting the antibody titration during assay optimization. Surmodics’ dried protein stabilizers and blockers provide alternative blocking mechanisms to achieve the best signal-to-noise ratios for each assay.

Due to the variability within patient samples, different blocking strategies are needed to dilute samples to achieve maximum assay performance. Both MatrixGuard™ and Surmodics™ Assay Diluent (Protein-Free) provide the gold standard in reducing false positives in your assay.

MatrixGuard (protein-containing) and Assay Diluent (protein-free) formulations provide two options to use when different methods are needed to block matrix interferences, while maintaining the clinical validity of the assay.

For IVD kit manufacturers requiring a strong, consistent blocking diluent across a variety of assays, Surmodics’ MatrixGuard Diluent provides unsurpassed blocking whereby matrix interferences are effectively blocked while the intended assay signal is maintained.

Unlike other diluents that either are marginally effective at blocking matrix interferences or alternatively block out true assay signal, MatrixGuard Diluent achieves the goal of maximum blockade of matrix interferences while simultaneously allowing signal to be maintained.

Incorporation of ISO 13485 Quality Standards

ISO 13485 Quality Standards ensure that companies manufacturing in-vitro diagnostic devices produce consistent, high-quality medical devices and related services. Assay developers gain advantages by applying these rigorous standards to their processes.

ISO 13485 Quality Standards help improve quality management systems, leading to better compliance with regulatory requirements. As a result, assay developers can enhance the reliability of immunoassays.

Companies using ISO 13485 Quality Standards can significantly reduce non-specific binding in their tests. They achieve this through effective control measures for reagents and laboratory practices. Improved handling procedures contribute to lower variability in results, thus enhancing specificity.

This commitment to quality assurance ultimately boosts diagnostic accuracy and reliability.

The Role of ELISA Substrates in Specificity and Sensitivity

ELISA substrates play a contributing role in improving specificity within immunoassays. They can affect the signal generated by antigen-antibody interactions, increasing the number of true negatives – thus, improving specificity. 

Therefore, choosing the best substrate becomes essential for achieving better specificity. Surmodics’ portfolio of BioFX™ colorimetric and chemiluminescent substrates offers the stability, low background and sensitivity needed to meet the demands of assay manufacturers. A range of substrate sensitivities are available for ELISA, Western Blot, ELISpot and immunohistochemistry applications.

Common Challenges in Achieving High Specificity

Common challenges in achieving high specificity include cross-reactivity issues and balancing sensitivity with specificity. These obstacles can complicate test results and lead to inaccuracies.

Cross-Reactivity Issues

Cross-reactivity presents a significant challenge in immunoassays. It occurs when antibodies bind to non-target epitopes, leading to false positives.

Assay developers must ensure that detected signals correspond to target analytes alone. This precision is vital for accurate results. Immunoassays rely on the specific interactions between antibody reagents and their intended targets to quantify biological molecules effectively.

Employing strategies like using high-quality stabilizers/blockers and substrates has a proven track record in minimizing cross-reactivity.

Sensitivity vs. Specificity

Along with specificity, sensitivity of an immunoassay plays a crucial role in the reliability and accuracy of a diagnostic application. Assay developers often face trade-offs between these two metrics. High sensitivity means that the test can detect even small amounts of the target antigen, which helps identify cases that may otherwise go unnoticed.

However, increasing sensitivity might compromise specificity, leading to more false positives.

Immunoassays quantify biological molecules based on specific antigen-antibody reactions. Yet, achieving this balance requires careful consideration of antibody quality and assay conditions. Developers must continuously optimize their processes to enhance accuracy while minimizing cross-reactivity issues.

Benefits of Enhanced Specificity in Immunoassays

Enhanced specificity in immunoassays leads to improved diagnostic accuracy and significantly reduces the occurrence of false positives and negatives. This advancement directly translates into better patient outcomes and more reliable research results.

Improved Diagnostic Accuracy

As we’ve now learned, high specificity in immunoassays leads to improved diagnostic accuracy. Assay developers understand that accurate detection of the target analyte is crucial. Specificity reduces false positives and negatives, ensuring reliable results.

Assay conditions also play an essential role in achieving enhanced accuracy. Excess concentrations of detection antibody can cause non-specific binding; therefore, optimizing these levels improves overall specificity.

High-quality blockers and diluents further improve assay performance by minimizing background noise during detection.

Reduced False Positives

Enhanced specificity leads to reduced false positives and accurate identification of true negatives in immunoassays. These improvements increase the accuracy of diagnostic tests.

This significant enhancement helps ensure that detected signals correspond accurately to target analytes rather than unrelated substances.

Conclusion

As we’ve now learned, high specificity in immunoassays leads to improved diagnostic accuracy. Assay developers understand that accurate detection of the target analyte is crucial. Specificity reduces false positives and improves detection of true negatives, ensuring reliable results.

Assay conditions also play an essential role in achieving enhanced accuracy. Excess concentrations of detection antibody can cause non-specific binding; therefore, optimizing these levels improves overall specificity.

High-quality blockers and diluents further improve assay performance by minimizing background noise during detection.

A focused approach to immunoassay specificity leads to more reliable diagnostics and scientific research. Ongoing improvements in assay design, reagents, and standards now offer new levels of accuracy for developers.

FAQs

1. What does specificity mean in an immunoassay?

Specificity means the ability of an immunoassay to detect only the target molecule, not unrelated substances. High specificity reduces false positives and improves test reliability.

2. Why do cross-reactions lower accuracy in immunoassays?

Cross-reactions happen when antibodies bind to similar but unintended molecules. This lowers accuracy because it causes incorrect results that can mislead research or diagnostics.

3. How can I improve specificity in my immunoassay protocol?

You can improve specificity by using highly purified capture proteins, optimizing buffer conditions, and selecting detection reagents with minimal off-target binding. Careful validation at each step is key for reliable outcomes.

4. What role does antibody selection play in achieving high assay specificity?

Choosing well-characterized and highly selective antibodies increases the chance of binding only your intended analyte. Rigorous testing ensures these antibodies perform as needed under actual assay conditions, which helps prevent interference from related compounds or background noise.